Thermo Fisher Scientific Deferred Taxes increased by 41.1% to $2.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 102.4%, from $1.04B to $2.11B. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows a downward trend with a -3.6% CAGR.
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
other_deferred_income_tax_liabilities_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.47B | $3.84B | $3.49B | $3.33B | $3.14B | $2.85B | $2.98B | $2.84B | $2.62B | $1.92B | $1.81B | $1.52B | $1.12B | $1.27B | $1.04B | $624.00M | $842.00M | $1.49B | $2.11B |
| QoQ Change | — | -10.2% | +161.9% | -9.0% | -4.8% | -5.6% | -9.3% | +4.5% | -4.5% | -7.8% | -26.6% | -5.8% | -16.3% | -25.9% | +12.9% | -17.9% | -40.1% | +34.9% | +77.3% | +41.1% |
| YoY Change | — | — | — | — | +103.9% | +114.3% | -25.7% | -14.8% | -14.6% | -16.6% | -32.5% | -39.1% | -46.7% | -57.1% | -34.0% | -42.5% | -58.8% | -25.0% | +17.7% | +102.4% |